{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:06:28Z","timestamp":1790172388108,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Microbiome"],"DOI":"10.1186\/s40168-024-01927-5","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T13:02:50Z","timestamp":1729688570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Metaproteomics reveals diet-induced changes in gut microbiome function according to Crohn\u2019s disease location"],"prefix":"10.1186","volume":"12","author":[{"given":"Stefano","family":"Levi Mortera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Marzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Rapisarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Marangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pirona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vernocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Michele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Del Chierico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Quintero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"Hazime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose M.","family":"Killian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Solis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mailenys","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana M.","family":"Damas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Proksell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Kerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar R.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Scaldaferri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Putignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"1927_CR1","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0140-6736(23)02586-2","volume":"403","author":"M Dolinger","year":"2024","unstructured":"Dolinger M, Torres J, Vermeire S. Crohn\u2019s disease. Lancet. 2024;403:1177\u201391.","journal-title":"Lancet"},{"key":"1927_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","volume":"6","author":"G Roda","year":"2020","unstructured":"Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn\u2019s disease. Nat Rev Dis Primer. 2020;6:22.","journal-title":"Nat Rev Dis Primer"},{"key":"1927_CR3","doi-asserted-by":"publisher","first-page":"e1323","DOI":"10.1016\/j.cgh.2021.08.031","volume":"20","author":"C-H Lo","year":"2022","unstructured":"Lo C-H, Khandpur N, Rossato SL, Lochhead P, Lopes EW, Burke KE, et al. Ultra-processed foods and risk of Crohn\u2019s disease and ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2022;20:e1323\u201337.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1927_CR4","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/ajcn\/63.5.741","volume":"63","author":"R Shoda","year":"1996","unstructured":"Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr. 1996;63:741\u20135.","journal-title":"Am J Clin Nutr"},{"key":"1927_CR5","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1038\/s41598-019-39232-z","volume":"9","author":"EA Scoville","year":"2019","unstructured":"Scoville EA, Allaman MM, Adams DW, Motley AK, Peyton SC, Ferguson SL, et al. Serum polyunsaturated fatty acids correlate with serum cytokines and clinical disease activity in Crohn\u2019s disease. Sci Rep. 2019;9:2882.","journal-title":"Sci Rep"},{"key":"1927_CR6","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/s41575-021-00512-7","volume":"18","author":"M Wolter","year":"2021","unstructured":"Wolter M, Grant ET, Boudaud M, Steimle A, Pereira GV, Martens EC, et al. Leveraging diet to engineer the gut microbiome. Nat Rev Gastroenterol Hepatol. 2021;18:885\u2013902.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1927_CR7","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1053\/j.gastro.2020.01.047","volume":"158","author":"WJ Sandborn","year":"2020","unstructured":"Sandborn WJ, Feagan BG, Loftus EV, Peyrin-Biroulet L, Van Assche G, D\u2019Haens G, et al. Efficacy and safety of Upadacitinib in a randomized trial of patients with Crohn\u2019s disease. Gastroenterology. 2020;158:2123-2138.e8.","journal-title":"Gastroenterology"},{"key":"1927_CR8","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","volume":"14","author":"J Torres","year":"2020","unstructured":"Torres J, Bonovas S, Doherty G, Kucharzik T, Gisbert JP, Raine T, et al. ECCO uidelines on therapeutics in Crohn\u2019s disease: medical treatment. J Crohns Colitis. 2020;14:4\u201322.","journal-title":"J Crohns Colitis"},{"key":"1927_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/jhn.12400","volume":"30","author":"DQ Holt","year":"2017","unstructured":"Holt DQ, Strauss BJ, Moore GT. Patients with inflammatory bowel disease and their treating clinicians have different views regarding diet. J Hum Nutr Diet. 2017;30:66\u201372.","journal-title":"J Hum Nutr Diet"},{"key":"1927_CR10","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1017\/S0029665121002846","volume":"80","author":"V Svolos","year":"2021","unstructured":"Svolos V, Gkikas K, Gerasimidis K. Diet and gut microbiota manipulation for the management of Crohn\u2019s disease and ulcerative colitis. Proc Nutr Soc. 2021;80:409\u201323.","journal-title":"Proc Nutr Soc"},{"key":"1927_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu12123749","volume":"12","author":"DL Suskind","year":"2020","unstructured":"Suskind DL, Lee D, Kim Y-M, Wahbeh G, Singh N, Braly K, et al. The specific carbohydrate diet and diet modification as induction therapy for pediatric Crohn\u2019s disease: a randomized diet controlled trial. Nutrients. 2020;12: 3749.","journal-title":"Nutrients"},{"key":"1927_CR12","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1053\/j.gastro.2018.12.002","volume":"156","author":"V Svolos","year":"2019","unstructured":"Svolos V, Hansen R, Nichols B, Quince C, Ijaz UZ, Papadopoulou RT, et al. Treatment of active Crohn\u2019s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology. 2019;156:1354-1367.e6.","journal-title":"Gastroenterology"},{"key":"1927_CR13","first-page":"1189","volume":"19","author":"J Fritsch","year":"2021","unstructured":"Fritsch J, Garces L, Quintero MA, Pignac-Kobinger J, Santander AM, Fern\u00e1ndez I, et al. Low-fat, high-fiber diet reduces markers of inflammation and dysbiosis and improves quality of life in patients with ulcerative colitis. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2021;19:1189-1199.e30.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"1927_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1053\/j.gastro.2004.04.061","volume":"127","author":"A Darfeuille-Michaud","year":"2004","unstructured":"Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser A-L, Barnich N, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn\u2019s disease. Gastroenterology. 2004;127:412\u201321.","journal-title":"Gastroenterology"},{"key":"1927_CR15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers D, Kugathasan S, Denson LA, V\u00e1zquez-Baeza Y, Van Treuren W, Ren B, et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe. 2014;15:382\u201392.","journal-title":"Cell Host Microbe"},{"key":"1927_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/gutjnl-2016-313235","volume":"66","author":"V Pascal","year":"2017","unstructured":"Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, et al. A microbial signature for Crohn\u2019s disease. Gut. 2017;66:813\u201322.","journal-title":"Gut"},{"key":"1927_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41591-018-0308-z","volume":"25","author":"B Yilmaz","year":"2019","unstructured":"Yilmaz B, Cohort Swiss IBD, Investigators Juillerat P, \u00d8y\u00e5s O, Ramon C, Bravo FD, et al. Microbial network disturbances in relapsing refractory Crohn\u2019s disease. Nat Med. 2019;25:323\u201336.","journal-title":"Nat Med"},{"key":"1927_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ismej.2013.185","volume":"8","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Geng J, Tang X, Fan H, Xu J, Wen X, et al. Spatial heterogeneity and co-occurrence patterns of human mucosal-associated intestinal microbiota. ISME J. 2014;8:881\u201393.","journal-title":"ISME J"},{"key":"1927_CR19","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1042\/BST20201201","volume":"50","author":"N Juge","year":"2022","unstructured":"Juge N. Relationship between mucosa-associated gut microbiota and human diseases. Biochem Soc Trans. 2022;50:1225\u201336.","journal-title":"Biochem Soc Trans"},{"key":"1927_CR20","doi-asserted-by":"publisher","unstructured":"Hern\u00e1ndez-Rocha C, Turpin W, Borowski K, Stempak JM, Sabic K, Gettler K, et al. After surgically induced remission, ileal and colonic mucosa-associated microbiota predicts Crohn\u2019s disease recurrence. Clin Gastroenterol Hepatol. 2024;S1542356524005925.\u00a0https:\/\/doi.org\/10.1016\/j.cgh.2024.06.022.","DOI":"10.1016\/j.cgh.2024.06.022"},{"key":"1927_CR21","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/1462-2920.16238","volume":"25","author":"J Armengaud","year":"2023","unstructured":"Armengaud J. Metaproteomics to understand how microbiota function: The crystal ball predicts a promising future. Environ Microbiol. 2023;25:115\u201325.","journal-title":"Environ Microbiol"},{"key":"1927_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081340","volume":"11","author":"C Henry","year":"2022","unstructured":"Henry C, Bassignani A, Berland M, Langella O, Sokol H, Juste C. Modern metaproteomics: a unique tool to characterize the active microbiome in health and diseases, and pave the road towards new biomarkers\u2014example of Crohn\u2019s disease and ulcerative colitis flare-ups. Cells. 2022;11: 1340.","journal-title":"Cells"},{"key":"1927_CR23","doi-asserted-by":"publisher","first-page":"e49138","DOI":"10.1371\/journal.pone.0049138","volume":"7","author":"AR Erickson","year":"2012","unstructured":"Erickson AR, Cantarel BL, Lamendella Darzi Y, Mongodin EF, Pan C, et al. Integrated metagenomics\/metaproteomics reveals human host-microbiota signatures of Crohn\u2019s disease. PLOSone. 2012;7:e49138.","journal-title":"PLOSone"},{"key":"1927_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1002\/ibd.21793","volume":"18","author":"LL Presley","year":"2012","unstructured":"Presley LL, Ye J, Li X, LeBlanc J, Zhang Z, Ruegger PM, et al. Host\u2013microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal\u2013luminal interface. Inflamm Bowel Dis. 2012;18:409\u201317.","journal-title":"Inflamm Bowel Dis."},{"key":"1927_CR25","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1136\/gutjnl-2012-303786","volume":"63","author":"C Juste","year":"2014","unstructured":"Juste C, Kreil DP, Beauvallet C, Guillot A, Vaca S, Carapito C, et al. Bacterial protein signals are associated with Crohn\u2019s disease. Gut. 2014;63:1566\u201377.","journal-title":"Gut"},{"key":"1927_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jcmgh.2016.05.003","volume":"2","author":"X Li","year":"2016","unstructured":"Li X, LeBlanc J, Elashoff D, McHardy I, Tong M, Roth B, et al. Microgeographic proteomic networks of the human colonic mucosa and their association with inflammatory bowel disease. Cell Mol Gastroenterol Hepatol. 2016;2:567\u201383.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1927_CR27","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1038\/s41467-018-05357-4","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Deeke SA, Ning Z, Starr AE, Butcher J, Li J, et al. Metaproteomics reveals associations between microbiome and intestinal extracellular vesicle proteins in pediatric inflammatory bowel disease. Nat Commun. 2018;9:2873.","journal-title":"Nat Commun"},{"key":"1927_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jprot.2019.04.009","volume":"201","author":"T Lehmann","year":"2019","unstructured":"Lehmann T, Schallert K, Vilchez-Vargas R, Benndorf D, P\u00fcttker S, Sydor S, et al. Metaproteomics of fecal samples of Crohn\u2019s disease and ulcerative colitis. J Proteomics. 2019;201:93\u2013103.","journal-title":"J Proteomics"},{"key":"1927_CR29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price J, Arze C, Ananthakrishnan AN, Schirmer M, Avila-Pacheco J, Poon TW, et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019;569:655\u201362.","journal-title":"Nature"},{"key":"1927_CR30","doi-asserted-by":"publisher","first-page":"4120","DOI":"10.1038\/s41467-020-17916-9","volume":"11","author":"X Zhang","year":"2020","unstructured":"Zhang X, Ning Z, Mayne J, Yang Y, Deeke SA, Walker K, et al. Widespread protein lysine acetylation in gut microbiome and its alterations in patients with Crohn\u2019s disease. Nat Commun. 2020;11:4120.","journal-title":"Nat Commun"},{"key":"1927_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s40168-022-01331-x","volume":"10","author":"CG Gonzalez","year":"2022","unstructured":"Gonzalez CG, Mills RH, Zhu Q, Sauceda C, Knight R, Dulai PS, et al. Location-specific signatures of Crohn\u2019s disease at a multi-omics scale. Microbiome. 2022;10:133.","journal-title":"Microbiome"},{"key":"1927_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ecco-jcc\/jjac110","volume":"17","author":"R Vitali","year":"2023","unstructured":"Vitali R, Palone F, Armuzzi A, Fulci V, Negroni A, Carissimi C, et al. Proteomic analysis identifies three reliable biomarkers of intestinal inflammation in the stools of patients with inflammatory bowel disease. J Crohns Colitis. 2023;17:92\u2013102.","journal-title":"J Crohns Colitis"},{"key":"1927_CR33","doi-asserted-by":"publisher","unstructured":"Abreu MT, Quintero MA, Garces L, Hazime H, Killian R, Faust KM, et al. A high-fiber, low-fat diet improves the symptoms and metabolic profile of patients with Crohn\u2019s disease. medRxiv. 2024. https:\/\/doi.org\/10.1101\/2024.08.30.24312853.","DOI":"10.1101\/2024.08.30.24312853"},{"key":"1927_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/s41575-021-00424-6","volume":"18","author":"R Atreya","year":"2021","unstructured":"Atreya R, Siegmund B. Location is important: differentiation between ileal and colonic Crohn\u2019s disease. Nat Rev Gastroenterol Hepatol. 2021;18:544\u201358.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1927_CR35","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.cgh.2019.04.040","volume":"17","author":"PS Dulai","year":"2019","unstructured":"Dulai PS, Singh S, Vande Casteele N, Boland BS, Rivera-Nieves J, Ernst PB, et al. Should we divide Crohn\u2019s disease into ileum-dominant and isolated colonic diseases? Clin Gastroenterol Hepatol. 2019;17:2634\u201343.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1927_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/apt.16536","volume":"54","author":"N Pierre","year":"2021","unstructured":"Pierre N, Sal\u00e9e C, Vieujean S, Bequet E, Merli A, Siegmund B, et al. Review article: distinctions between ileal and colonic Crohn\u2019s disease: from physiology to pathology. Aliment Pharmacol Ther. 2021;54:779\u201391.","journal-title":"Aliment Pharmacol Ther"},{"key":"1927_CR37","doi-asserted-by":"publisher","first-page":"18699","DOI":"10.1038\/s41598-021-96942-z","volume":"11","author":"GCA Amos","year":"2021","unstructured":"Amos GCA, Sergaki C, Logan A, Iriarte R, Bannaga A, Chandrapalan S, et al. Exploring how microbiome signatures change across inflammatory bowel disease conditions and disease locations. Sci Rep. 2021;11:18699.","journal-title":"Sci Rep"},{"key":"1927_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MIB.0000000000000662","volume":"22","author":"T Naftali","year":"2016","unstructured":"Naftali T, Reshef L, Kovacs A, Porat R, Amir I, Konikoff FM, et al. Distinct microbiotas are associated with ileum-restricted and colon-involving Crohn\u02bcs disease. Inflamm Bowel Dis. 2016;22:293\u2013302.","journal-title":"Inflamm Bowel Dis"},{"key":"1927_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232415982","volume":"23","author":"S Levi Mortera","year":"2022","unstructured":"Levi Mortera S, Marzano V, Vernocchi P, Matteoli MC, Guarrasi V, Gardini S, et al. Functional and taxonomic traits of the gut microbiota in type 1 diabetes children at the onset: a metaproteomic study. Int J Mol Sci. 2022;23: 15982.","journal-title":"Int J Mol Sci"},{"key":"1927_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8695-8_1","volume":"1841","author":"JR Wi\u015bniewski","year":"2018","unstructured":"Wi\u015bniewski JR. Filter-aided sample preparation for proteome analysis. Methods Mol Biol Clifton NJ. 2018;1841:3\u201310.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"1927_CR41","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.csbj.2022.01.018","volume":"20","author":"JA Blakeley-Ruiz","year":"2022","unstructured":"Blakeley-Ruiz JA, Kleiner M. Considerations for constructing a protein sequence database for metaproteomics. Comput Struct Biotechnol J. 2022;20:937\u201352.","journal-title":"Comput Struct Biotechnol J"},{"key":"1927_CR42","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40168-016-0176-z","volume":"4","author":"X Zhang","year":"2016","unstructured":"Zhang X, Ning Z, Mayne J, Moore JI, Li J, Butcher J, et al. MetaPro-IQ: a universal metaproteomic approach to studying human and mouse gut microbiota. Microbiome. 2016;4:4.","journal-title":"Microbiome"},{"key":"1927_CR43","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40168-017-0375-2","volume":"5","author":"K Cheng","year":"2017","unstructured":"Cheng K, Ning Z, Zhang X, Li L, Liao B, Mayne J, et al. MetaLab: an automated pipeline for metaproteomic data analysis. Microbiome. 2017;5:5.","journal-title":"Microbiome"},{"key":"1927_CR44","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2244139","volume":"15","author":"Y Xia","year":"2023","unstructured":"Xia Y. Statistical normalization methods in microbiome data with application to microbiome cancer research. Gut Microbes. 2023;15: 2244139.","journal-title":"Gut Microbes"},{"key":"1927_CR45","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.13525","volume":"10","author":"S Plancade","year":"2022","unstructured":"Plancade S, Berland M, Blein-Nicolas M, Langella O, Bassignani A, Juste C. A combined test for feature selection on sparse metaproteomics data\u2014an alternative to missing value imputation. PeerJ. 2022;10: e13525.","journal-title":"PeerJ"},{"key":"1927_CR46","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"1927_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050977","volume":"9","author":"L Aldars-Garc\u00eda","year":"2021","unstructured":"Aldars-Garc\u00eda L, Chaparro M, Gisbert JP. Systematic review: the gut microbiome and its potential clinical application in inflammatory bowel disease. Microorganisms. 2021;9:977.","journal-title":"Microorganisms"},{"key":"1927_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158361","volume":"23","author":"MA N\u00fa\u00f1ez-S\u00e1nchez","year":"2022","unstructured":"N\u00fa\u00f1ez-S\u00e1nchez MA, Melgar S, O\u2019Donoghue K, Mart\u00ednez-S\u00e1nchez MA, Fern\u00e1ndez-Ruiz VE, Ferrer-G\u00f3mez M, et al. Crohn\u2019s disease, host\u2013microbiota interactions, and immunonutrition: dietary strategies targeting gut microbiome as novel therapeutic approaches. Int J Mol Sci. 2022;23: 8361.","journal-title":"Int J Mol Sci"},{"key":"1927_CR49","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1097\/MIB.0000000000000110","volume":"20","author":"R Sigall-Boneh","year":"2014","unstructured":"Sigall-Boneh R, Pfeffer-Gik T, Segal I, Zangen T, Boaz M, Levine A. Partial enteral nutrition with a Crohn\u02bcs disease exclusion diet is effective for induction of remission in children and young adults with Crohn\u02bcs disease. Inflamm Bowel Dis. 2014;20:1353\u201360.","journal-title":"Inflamm Bowel Dis"},{"key":"1927_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1053\/j.gastro.2021.05.047","volume":"161","author":"JD Lewis","year":"2021","unstructured":"Lewis JD, Sandler RS, Brotherton C, Brensinger C, Li H, Kappelman MD, et al. A randomized trial comparing the specific carbohydrate diet to a editerranean diet in adults with Crohn\u2019s disease. Gastroenterology. 2021;161:837-852.e9.","journal-title":"Gastroenterology"},{"key":"1927_CR51","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1053\/j.gastro.2019.09.024","volume":"158","author":"SR Cox","year":"2020","unstructured":"Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, et al. Effects of low FODMAP diet on symptoms, fecal microbiome, and markers of inflammation in patients with quiescent inflammatory bowel disease in a randomized trial. Gastroenterology. 2020;158:176-188.e7.","journal-title":"Gastroenterology"},{"key":"1927_CR52","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/s41564-018-0267-7","volume":"3","author":"AT Reese","year":"2018","unstructured":"Reese AT, Pereira FC, Schintlmeister A, Berry D, Wagner M, Hale LP, et al. Microbial nitrogen limitation in the mammalian large intestine. Nat Microbiol. 2018;3:1441\u201350.","journal-title":"Nat Microbiol"},{"key":"1927_CR53","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1073\/pnas.0804812105","volume":"105","author":"H Sokol","year":"2008","unstructured":"Sokol H, Pigneur B, Watterlot L, Lakhdari O, Berm\u00fadez-Humar\u00e1n LG, Gratadoux J-J, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105:16731\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1927_CR54","doi-asserted-by":"publisher","first-page":"18880","DOI":"10.1038\/s41598-019-55290-9","volume":"9","author":"K Kowalska-Duplaga","year":"2019","unstructured":"Kowalska-Duplaga K, Gosiewski T, Kapusta P, Sroka-Oleksiak A, W\u0119drychowicz A, Pieczarkowski S, et al. Differences in the intestinal microbiome of healthy children and patients with newly diagnosed Crohn\u2019s disease. Sci Rep. 2019;9:18880.","journal-title":"Sci Rep"},{"key":"1927_CR55","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gutjnl-2014-307649","volume":"65","author":"E Qu\u00e9vrain","year":"2016","unstructured":"Qu\u00e9vrain E, Maubert MA, Michon C, Chain F, Marquant R, Tailhades J, et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn\u2019s disease. Gut. 2016;65:415\u201325.","journal-title":"Gut"},{"key":"1927_CR56","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/ismej.2013.80","volume":"7","author":"L Rigottier-Gois","year":"2013","unstructured":"Rigottier-Gois L. Dysbiosis in inflammatory bowel diseases: the oxygen hypothesis. ISME J. 2013;7:1256\u201361.","journal-title":"ISME J"},{"key":"1927_CR57","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2021.1875796","volume":"13","author":"X Liu","year":"2021","unstructured":"Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, et al. Blautia\u2014a new functional genus with potential probiotic properties? Gut Microbes. 2021;13: 1875796.","journal-title":"Gut Microbes"},{"key":"1927_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2023.105707","volume":"107","author":"A Gregor","year":"2023","unstructured":"Gregor A, Auernigg-Haselmaier S, Malleier M, Bruckberger S, S\u00e9neca J, Pjevac P, et al. Fiber consumption stimulates the activity of microbial bile salt hydrolases. J Funct Foods. 2023;107: 105707.","journal-title":"J Funct Foods"},{"key":"1927_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13073-016-0299-7","volume":"8","author":"J Chen","year":"2016","unstructured":"Chen J, Wright K, Davis JM, Jeraldo P, Marietta EV, Murray J, et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis. Genome Med. 2016;8:43.","journal-title":"Genome Med"},{"key":"1927_CR60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2017.1406584","volume":"9","author":"LF Gomez-Arango","year":"2018","unstructured":"Gomez-Arango LF, Barrett HL, Wilkinson SA, Callaway LK, McIntyre HD, Morrison M, et al. Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women. Gut Microbes. 2018;9:189\u2013201.","journal-title":"Gut Microbes"},{"key":"1927_CR61","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41579-021-00559-y","volume":"19","author":"A Tett","year":"2021","unstructured":"Tett A, Pasolli E, Masetti G, Ercolini D, Segata N. Prevotella diversity, niches and interactions with the human host. Nat Rev Microbiol. 2021;19:585\u201399.","journal-title":"Nat Rev Microbiol"},{"key":"1927_CR62","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1128\/JCM.01004-06","volume":"44","author":"U Gophna","year":"2006","unstructured":"Gophna U, Sommerfeld K, Gophna S, Doolittle WF, Veldhuyzen van Zanten SJO. Differences between tissue-associated intestinal microfloras of patients with Crohn\u2019s disease and ulcerative colitis. J Clin Microbiol. 2006;44:4136\u201341.","journal-title":"J Clin Microbiol"},{"key":"1927_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104707","volume":"150","author":"N Xu","year":"2021","unstructured":"Xu N, Bai X, Cao X, Yue W, Jiang W, Yu Z. Changes in intestinal microbiota and correlation with TLRs in ulcerative colitis in the coastal area of northern China. Microb Pathog. 2021;150: 104707.","journal-title":"Microb Pathog"},{"key":"1927_CR64","doi-asserted-by":"publisher","first-page":"6179","DOI":"10.1128\/IAI.69.10.6179-6185.2001","volume":"69","author":"AG Torres","year":"2001","unstructured":"Torres AG, Redford P, Welch RA, Payne SM. TonB-dependent systems of uropathogenic Escherichia coli\u202f: Aerobactin and heme transport and TonB are required for virulence in the mouse. O\u2019Brien AD, editor. Infect Immun. 2001;69:6179\u201385.","journal-title":"Infect Immun"},{"key":"1927_CR65","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41564-021-01050-3","volume":"7","author":"RH Mills","year":"2022","unstructured":"Mills RH, Dulai PS, V\u00e1zquez-Baeza Y, Sauceda C, Daniel N, Gerner RR, et al. Multi-omics analyses of the ulcerative colitis gut microbiome link Bacteroides vulgatus proteases with disease severity. Nat Microbiol. 2022;7:262\u201376.","journal-title":"Nat Microbiol"}],"container-title":["Microbiome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-024-01927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40168-024-01927-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40168-024-01927-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T01:10:01Z","timestamp":1739409001000},"score":1,"resource":{"primary":{"URL":"https:\/\/microbiomejournal.biomedcentral.com\/articles\/10.1186\/s40168-024-01927-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1186\/s40168-024-01927-5","relation":{},"ISSN":["2049-2618"],"issn-type":[{"value":"2049-2618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"14 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MTA has received research funding from The Leona M. and Harry B. Helmsley Charitable Trust and the Crohn\u2019s and Colitis Foundation. She has served as a consultant for or is on the advisory board of the following companies: AbbVie Inc., Amgen, Bristol Myers Squibb, Celsius Therapeutics, Eli Lilly and Company, Gilead Sciences, Janssen Pharmaceuticals, Matera Prima, and Pfizer Pharmaceutical. MTA has served as a teacher, lecturer, or speaker for the following companies: Janssen Pharmaceuticals and Takeda Pharmaceuticals. All other authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}